Long-Term Bisphosphonates May Be OK for Select Patients: An analysis of long-term bisphosphonate use, evaluating a composite endpoint of both vertebral and nonvertebral fractures in postmenopausal women, showed minimal benefit of continued bisphosphonate treatment beyond five years, although some patients at high risk might consider taking these agents longer.

Given how many EDSers are subject to early osteoarthritis, this falls in the category of probably good news. More through the link.
Shared publicly